Ross Albert

Title: Innovations in Immunomodulation by Ross Albert

Introduction

Ross Albert is an accomplished inventor based in Philadelphia, PA (US). He has made significant contributions to the field of immunology through his innovative research and patent work. His focus on serotonin family receptors has opened new avenues for therapeutic applications in immune diseases.

Latest Patents

Ross Albert holds a patent titled "Immunomodulation and effect on cell processes relating to serotonin family receptors." This invention reveals that signaling via serotonin type 1B, 2, 4, and 6 receptors plays a crucial role in T cell activation. By inhibiting this signaling, it is possible to modulate the immune response, which can be beneficial for treating various immune diseases. Furthermore, his research indicates that inhibiting serotonin signaling during the cell cycle can induce apoptosis and morphological changes in cells. These findings have potential implications for selective cell killing and the identification of compounds that inhibit serotonergic signaling.

Career Highlights

Ross Albert is affiliated with Drexel University, where he continues to advance his research in immunology. His work has garnered attention for its innovative approach to understanding immune responses and developing potential therapeutics.

Collaborations

He collaborates with notable colleagues, including Harold Carter Davidson and Bradford A Jameson. Their combined expertise enhances the research efforts in the field of immunomodulation.

Conclusion

Ross Albert's contributions to immunology through his patent and research are paving the way for new treatments for immune diseases. His innovative work exemplifies the importance of scientific research in developing effective therapeutics.